Stock Report

All about this stock under one free report Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Dr. Lal Pathlabs Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: LALPATHLAB | BSE: 539524

₹1,931.10

up-down-arrow ₹-5.30 (-0.27%)

As on 28-Aug-2026IST

Market cap

info icon

₹32,407 Cr

Revenue (TTM)

info icon

₹2,891 Cr

P/E Ratio

info icon

59.8

P/B Ratio

info icon

12.4

Div. Yield

info icon

1.1 %

Edit peer-selector-edit
Dr. Lal Pathlabs Global Health Krishna Institute Krsnaa Diagnostics Medicamen Biotech Metropolis Health Sastasundar Vent Suraksha Diagnostic Thyrocare Tech Vijaya Diagno
Market cap (₹ Cr)
 32,407 39,538 32,332 1,829 337 12,199 940 1,766 9,311 14,953
Revenue (₹ Cr)
 2,891 4,683 4,213 815 203 1,710 1,468 325 876 857
Net Profit (₹ Cr)
 546.30 552.34 190.80 97.53 10.04 202.82 -26.05 35.07 174.04 187.49
Net Margin (%)
 18.23 11.55 4.49 11.31 4.87 11.70 -1.72 10.67 19.50 21.32
RoE (%)
 23.03 14.93 9.45 10.24 3.93 14.13 -2.93 15.06 32.40 20.58
Price to Earnings
 59.80 71.09 158.26 18.76 31.12 60.50 -- 49.32 52.81 79.76
Price-To-Book
 12.40 9.62 8.54 1.83 1.25 7.82 1.46 6.85 14.79 14.85

Income Statement (₹ Cr)

Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Operating Revenue arrow
2,890.80 4,683.37 4,212.50 857.13 1,710.00
Total Income arrow
2,995.90 4,783.78 4,248.00 879.41 1,733.17
Total Expenditure arrow
2,053.10 3,704.62 3,379.70 495.19 1,287.72
EBITDA arrow
837.70 978.75 832.80 361.94 422.28
Depreciation arrow
171.60 246.41 330.60 96.06 135.28
EBIT arrow
666.10 732.34 502.20 265.89 287.00
Interest arrow
24.40 92.01 253.30 36.75 25.53
Other Income arrow
105.10 100.41 35.50 22.28 23.17
Exceptional Items arrow
-30.10 -20.61 -11.20 0.00 -8.99
Profit before Tax arrow
716.70 720.14 273.20 251.42 275.66
Provision for Tax arrow
170.40 167.80 82.40 63.93 72.84
Profit after Tax arrow
546.30 552.34 190.80 187.49 202.82

Liabilities (₹ Cr)

Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Shareholder's Funds arrow
2,508.20 3,961.57 2,247.40 957.15 1,513.16
Minority Interest arrow
-4.40 3.84 9.90 0.00 -1.20
Non-Current Liabilities arrow
154.00 1,293.60 3,961.30 426.03 279.48
Current Liabilities arrow
450.70 627.13 1,238.90 123.87 334.02
Total Liabilities arrow
3,139.97 5,905.00 7,690.70 1,507.05 2,524.76

Assets (₹ Cr)

Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Non-Current Assets arrow
1,176.30 3,128.95 5,416.90 737.24 1,415.30
Current Assets arrow
1,566.60 1,674.92 937.40 321.90 468.61
Total Assets arrow
3,139.97 5,905.00 7,690.70 1,507.05 2,524.76
Total Debt* arrow
0.00 631.08 3,244.00 0.00 18.73
Net Current Assets arrow
1,115.90 1,047.79 -301.50 198.03 134.59
Contingent Liabilities arrow
16.76 100.01 81.10 0.13 10.08

Cashflow (₹ Cr)

Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Cash From Operating Activities arrow
635.61 714.39 510.80 270.59 350.70
Cash Flow from Investing Activities arrow
-421.86 -1,089.11 -1,451.70 -174.22 -223.13
Cash from Financing Activities arrow
-263.57 271.85 940.30 -69.49 -115.29
Net Cash Inflow / Outflow arrow
-49.83 -102.87 -0.60 26.88 12.28

Ratios

Profitability Ratios

 Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
ROCE (%) arrow
29.56 19.38 11.51 30.28 20.03
ROE (%) arrow
23.03 14.93 9.45 20.58 14.13
ROA (%) arrow
18.64 10.35 2.83 13.49 10.13
EBIT Margin (%) arrow
23.04 15.64 11.92 31.02 16.78
Net Margin (%) arrow
18.23 11.55 4.49 21.32 11.70
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Revenue Growth (%) arrow
14.29 21.27 30.90 20.18 21.80
EBIT Growth (%) arrow
15.64 0.94 -16.88 26.22 43.53
Net Profit Growth (%) arrow
5.38 3.43 -52.81 24.27 32.87
EPS Growth (%) arrow
-30.51 2.70 -42.60 23.44 -16.64
Book Value Growth (%) arrow
15.41 16.51 5.13 21.86 13.54

Valuation Ratios

 Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Price / Earnings arrow
45.29 69.04 145.70 79.61 23.90
Price / Book Value arrow
12.40 9.62 8.54 14.85 7.82
Dividend Yield (%) arrow
1.06 0.03 0.00 0.14 0.85
EV/EBITDA arrow
37.09 39.89 42.61 40.54 28.45
Market Cap (₹ Cr) arrow
22,015.15 25,841.07 24,901.98 8,864.05 8,992.90

Solvency Ratios

 Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Debt to Equity arrow
0.00 0.15 1.19 0.00 0.00
Short term debt to equity ratio arrow
-- -- 0.15 -- 0.01
Current Ratio arrow
3.48 2.67 0.76 2.60 1.40
Quick Ratio arrow
3.38 2.54 0.68 2.56 1.27
Interest Coverage arrow
30.37 8.83 2.08 7.84 11.80

Operating Efficiency Ratios

 Dr. Lal Pathlabs Global Health Krishna Institute Vijaya Diagno Metropolis Health
Debtors to sales (%) arrow
3.83 8.78 13.16 2.43 9.96
Asset Turnover arrow
0.99 0.88 0.62 0.62 0.85
Receivable days arrow
13.13 29.09 44.38 7.98 35.29
Inventory Days arrow
5.28 6.05 7.52 2.20 10.35
Payable days arrow
118.67 80.04 133.54 136.27 143.56
Cash Conversion Cycle arrow
-100.26 -44.90 -81.64 -126.08 -97.92
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...